Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Change in Cash (2023 - 2025)

Historic Change in Cash for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $71.6 million.

  • Zenas BioPharma's Change in Cash fell 5936.66% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$244.6 million, marking a year-over-year decrease of 18499.7%. This contributed to the annual value of $262.9 million for FY2024, which is 263949.96% up from last year.
  • Latest data reveals that Zenas BioPharma reported Change in Cash of $71.6 million as of Q3 2025, which was down 5936.66% from -$152.5 million recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Change in Cash peaked at $176.1 million during Q3 2024, and registered a low of -$152.5 million during Q2 2025.
  • Its 3-year average for Change in Cash is $5.4 million, with a median of -$17.6 million in 2023.
  • Data for Zenas BioPharma's Change in Cash shows a peak YoY increase of 5936.66% (in 2025) and a maximum YoY decrease of 52571.31% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Zenas BioPharma's Change in Cash stood at -$15.5 million in 2023, then tumbled by 160.74% to -$40.3 million in 2024, then skyrocketed by 277.59% to $71.6 million in 2025.
  • Its Change in Cash was $71.6 million in Q3 2025, compared to -$152.5 million in Q2 2025 and -$123.3 million in Q1 2025.